These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1910891)

  • 1. Improving colorectal cancer screening in a medical residents' primary care clinic.
    Struewing JP; Pape DM; Snow DA
    Am J Prev Med; 1991; 7(2):75-81. PubMed ID: 1910891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of family physicians in increasing annual fecal occult blood test screening coverage: a prospective intervention study.
    Vinker S; Nakar S; Rosenberg E; Kitai E
    Isr Med Assoc J; 2002 Jun; 4(6):424-5. PubMed ID: 12073414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer on the front line.
    Lemon SC; Zapka JG; Estabrook B; Erban S; Luckmann R
    Am J Gastroenterol; 2003 Apr; 98(4):915-23. PubMed ID: 12738477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
    Young WF; McGloin J; Zittleman L; West DR; Westfall JM
    J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.
    Schroy PC; Geller AC; Crosier Wood M; Page M; Sutherland L; Holm LJ; Heeren T
    Prev Med; 2001 Nov; 33(5):381-91. PubMed ID: 11676578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does use of the Coloscreen Self-Test improve patient compliance with fecal occult blood screening?
    Park SI; Saxe JC; Weesner RE
    Am J Gastroenterol; 1993 Sep; 88(9):1391-4. PubMed ID: 8362837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
    Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center.
    Fitzgibbon ML; Ferreira MR; Dolan NC; Davis TC; Rademaker AW; Wolf MS; Liu D; Gorby N; Schmitt BP; Bennett CL
    Health Promot Pract; 2007 Jul; 8(3):273-81. PubMed ID: 17606952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to colorectal cancer screening: inadequate knowledge by physicians.
    Gennarelli M; Jandorf L; Cromwell C; Valdimarsdottir H; Redd W; Itzkowitz S
    Mt Sinai J Med; 2005 Jan; 72(1):36-44. PubMed ID: 15682261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of an evidence-based lecture and clinical prompt as methods to improve quality of care in colorectal cancer screening.
    Seres KA; Kirkpatrick AC; Tierney WM
    Am J Gastroenterol; 2009 Feb; 104(2):420-5. PubMed ID: 19190610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge of colorectal cancer among older persons.
    Weinrich SP; Weinrich MC; Boyd MD; Johnson E; Frank-Stromborg M
    Cancer Nurs; 1992 Oct; 15(5):322-30. PubMed ID: 1423251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
    Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
    J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening.
    Ling BS; Schoen RE; Trauth JM; Wahed AS; Eury T; Simak DM; Solano FX; Weissfeld JL
    Arch Intern Med; 2009 Jan; 169(1):47-55. PubMed ID: 19139323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening: physician attitudes and practices.
    Taylor ML; Anderson R
    WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.